Literature DB >> 31795838

Genomic testing is best integrated into clinical practice when it is actionable.

Rachele M Hendricks-Sturrup1,2, Amy Linsky3,4, Christine Y Lu1,2, Jason L Vassy2,4.   

Abstract

Entities:  

Keywords:  familial risk; genomics; implementation; pharmacogenomics; polygenic risk scoring

Year:  2019        PMID： 31795838     DOI： 10.2217/pme-2019-0106

Source DB:  PubMed          Journal:  Per Med        ISSN： 1741-0541            Impact factor:   2.512


× No keyword cloud information.
  4 in total

1.  Appraisal and development of evidence-based clinical decision support to enable perioperative pharmacogenomic application.

Authors:  Brittany A Borden; Ellie H Jhun; Keith Danahey; Emily Schierer; Jeffrey L Apfelbaum; Magdalena Anitescu; Randall Knoebel; Sajid Shahul; Tien M Truong; Mark J Ratain; Peter H O'Donnell
Journal:  Pharmacogenomics J       Date:  2021-08-10       Impact factor: 3.245

2.  Actionability of commercial laboratory sequencing panels for newborn screening and the importance of transparency for parental decision-making.

Authors:  Daniela M DeCristo; Laura V Milko; Julianne M O'Daniel; Ann Katherine M Foreman; Lonna F Mollison; Bradford C Powell; Cynthia M Powell; Jonathan S Berg
Journal:  Genome Med       Date:  2021-03-29       Impact factor: 11.117

3.  Public Interest in Population Genetic Screening for Cancer Risk.

Authors:  Megan C Roberts; Kimberly S Foss; Gail E Henderson; Sabrina N Powell; Katherine W Saylor; Karen E Weck; Laura V Milko
Journal:  Front Genet       Date:  2022-07-22       Impact factor: 4.772

4.  Pharmacogenomic Biomarkers in US FDA-Approved Drug Labels (2000-2020).

Authors:  Jeeyun A Kim; Rachel Ceccarelli; Christine Y Lu
Journal:  J Pers Med       Date:  2021-03-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.